143 related articles for article (PubMed ID: 36819468)
1. Clinical outcomes of patients treated with template-based high-dose-rate interstitial brachytherapy boost for post-operative recurrent gynecological malignancies: A retrospective analysis.
Mulye G; Gurram L; Chopra S; Gupta S; Ghosh J; Gulia S; Maheshwari A; Kerkar R; Shylasree TS; Scaria L; A D; Ghadi Y; Kohle S; Kadam S; Mahantshetty U
J Contemp Brachytherapy; 2022 Dec; 14(6):560-567. PubMed ID: 36819468
[TBL] [Abstract][Full Text] [Related]
2. Template-based high-dose-rate interstitial brachytherapy in gynecologic cancers: a single institutional experience.
Mahantshetty U; Shrivastava S; Kalyani N; Banerjee S; Engineer R; Chopra S
Brachytherapy; 2014; 13(4):337-42. PubMed ID: 24176863
[TBL] [Abstract][Full Text] [Related]
3. Retrospective analysis of role of interstitial brachytherapy using template (MUPIT) in locally advanced gynecological malignancies.
Nandwani PK; Vyas RK; Neema JP; Suryanarayan UK; Bhavsar DC; Jani KR
J Cancer Res Ther; 2007; 3(2):111-5. PubMed ID: 17998736
[TBL] [Abstract][Full Text] [Related]
4. The role of interstitial brachytherapy using template in locally advanced gynecological malignancies.
Agrawal PP; Singhal SS; Neema JP; Suryanarayan UK; Vyas RK; Rathi AK; Bahadur AK
Gynecol Oncol; 2005 Oct; 99(1):169-75. PubMed ID: 16081150
[TBL] [Abstract][Full Text] [Related]
5. Iridium-192 transperineal interstitial brachytherapy for locally advanced or recurrent gynecological malignancies.
Gupta AK; Vicini FA; Frazier AJ; Barth-Jones DC; Edmundson GK; Mele E; Gustafson GS; Martinez AA
Int J Radiat Oncol Biol Phys; 1999 Mar; 43(5):1055-60. PubMed ID: 10192355
[TBL] [Abstract][Full Text] [Related]
6. Can combined intracavitary/interstitial approach be an alternative to interstitial brachytherapy with the Martinez Universal Perineal Interstitial Template (MUPIT) in computed tomography-guided adaptive brachytherapy for bulky and/or irregularly shaped gynecological tumors?
Oike T; Ohno T; Noda SE; Kiyohara H; Ando K; Shibuya K; Tamaki T; Takakusagi Y; Sato H; Nakano T
Radiat Oncol; 2014 Oct; 9():222. PubMed ID: 25319341
[TBL] [Abstract][Full Text] [Related]
7. Image-guided vulvovaginal interstitial brachytherapy in the treatment of primary and recurrent gynecological malignancies.
De Ieso PB; Mullassery V; Shrimali R; Lowe G; Bryant L; Hoskin PJ
Brachytherapy; 2012; 11(4):306-10. PubMed ID: 21996537
[TBL] [Abstract][Full Text] [Related]
8. Efficacy and tolerance of high-dose-rate brachytherapy boost after external radiotherapy in the treatment of squamous cell carcinoma of the anal canal.
Bertin E; Benezery K; Kee DLC; François E; Evesque L; Gautier M; Gerard JP; Hannoun-Levi JM; Falk AT
J Contemp Brachytherapy; 2018 Dec; 10(6):522-531. PubMed ID: 30662475
[TBL] [Abstract][Full Text] [Related]
9. Image and laparoscopic guided interstitial brachytherapy for locally advanced primary or recurrent gynaecological cancer using the adaptive GEC ESTRO target concept.
Fokdal L; Tanderup K; Nielsen SK; Christensen HK; Røhl L; Pedersen EM; Schønemann NK; Lindegaard JC
Radiother Oncol; 2011 Sep; 100(3):473-9. PubMed ID: 21924784
[TBL] [Abstract][Full Text] [Related]
10. Institutional experience using interstitial brachytherapy for the treatment of primary and recurrent pelvic malignancies.
Aridgides P; Onderdonk B; Cunningham M; Daugherty E; Du L; Bunn WD; Agarwal R; Hahn SS
J Contemp Brachytherapy; 2016 Jun; 8(3):173-80. PubMed ID: 27504125
[TBL] [Abstract][Full Text] [Related]
11. Modified Houdek vault applicator for high-dose-rate brachytherapy: a technical report and case series.
Krishnamurthy R; Gurram L; Ghadi Y; Aravindhan D; Scaria L; Kohle S; Kadam S; Chopra S; Mahantshetty U
J Contemp Brachytherapy; 2021 Dec; 13(6):649-654. PubMed ID: 35079251
[TBL] [Abstract][Full Text] [Related]
12. Reporting of dose-volume specifications for "Martinez Universal Perineal Interstitial Template-based interstitial high-dose-rate brachytherapy for gynecological cancers" according to International Commission on Radiation Units and Measurements 58 with early clinical outcomes.
Sood S; Gurram L; Aravindakshan D; Paul J; Chopra S; Swamidas J; Patil A; Mahantshetty U
Brachytherapy; 2021; 20(3):550-556. PubMed ID: 33648892
[TBL] [Abstract][Full Text] [Related]
13. High-dose-rate interstitial brachytherapy for the treatment of high-volume locally recurrent endometrial carcinoma.
Huang K; D'Souza D; Patil N; Velker V; Leung E; Stitt L; Whiston F; Sugimoto A; McGee J; Prefontaine M
Brachytherapy; 2016; 15(5):543-8. PubMed ID: 27475479
[TBL] [Abstract][Full Text] [Related]
14. Dose optimization in gynecological 3D image based interstitial brachytherapy using martinez universal perineal interstitial template (MUPIT) -an institutional experience.
Sharma PK; Sharma PK; Swamidas JV; Mahantshetty U; Deshpande DD; Manjhi J; Rai DV
J Med Phys; 2014 Jul; 39(3):197-202. PubMed ID: 25190999
[TBL] [Abstract][Full Text] [Related]
15. One-week vaginal brachytherapy schedule as exclusive adjuvant post-operative treatment in intermediate- and high-intermediate-risk endometrial cancer patients.
De Sanctis V; Musio D; De Felice F; Marampon F; Valeriani M; Bonome P; Anzellini D; Facondo G; Vullo G; Massaro M; Di Staso M; Bonfili P; Chalaszczyk A; Gravina GL; Tombolini V; Osti MF
J Contemp Brachytherapy; 2020 Apr; 12(2):124-130. PubMed ID: 32395136
[TBL] [Abstract][Full Text] [Related]
16. Computed Tomography-Based Interstitial Brachytherapy for Recurrent Cervical Carcinoma in the Vaginal Apex.
Engineer R; Chopra S; Shukla R; Mahantshetty U; Phurailatpam R; Ghadi Y; Gupta S; Shrivastava SK
Clin Oncol (R Coll Radiol); 2022 Jan; 34(1):e1-e6. PubMed ID: 34716084
[TBL] [Abstract][Full Text] [Related]
17. High-dose-rate brachytherapy boost for locally advanced cervical cancer: Oncological outcome and toxicity analysis of 4 fractionation schemes.
le Guyader M; Lam Cham Kee D; Thamphya B; Schiappa R; Gautier M; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jan; 32():15-23. PubMed ID: 34816022
[TBL] [Abstract][Full Text] [Related]
18. High-dose-rate brachytherapy boost for elderly patients with intermediate to high-risk prostate cancer: 5-year clinical outcome of the PROSTAGE cohort.
Marotte D; Gal J; Schiappa R; Gautier M; Boulahssass R; Chand-Fouche ME; Hannoun-Levi JM
Clin Transl Radiat Oncol; 2022 Jul; 35():104-109. PubMed ID: 35692263
[TBL] [Abstract][Full Text] [Related]
19. Long term results of a prospective dose escalation phase-II trial: interstitial pulsed-dose-rate brachytherapy as boost for intermediate- and high-risk prostate cancer.
Lettmaier S; Lotter M; Kreppner S; Strnad A; Fietkau R; Strnad V
Radiother Oncol; 2012 Aug; 104(2):181-6. PubMed ID: 22853851
[TBL] [Abstract][Full Text] [Related]
20. Inverse-planned gynecologic high-dose-rate interstitial brachytherapy: clinical outcomes and dose--volume histogram analysis.
Thibault I; Lavallée MC; Aubin S; Laflamme N; Vigneault E
Brachytherapy; 2012; 11(3):181-91. PubMed ID: 21862418
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
